Dexmedetomidine Sedation With Third Molar Surgery

Stopped early · Phase 4

Conditions studied: Anesthesia

In brief

Intravenous sedation is used frequently for the relief of pain and anxiety associated with oral surgical procedures performed under local anesthesia. The purpose of this study is to learn about patient and surgeon satisfaction with sedation using Dexmedetomidine in combination with midazolam alone or with midazolam plus low dose ketamine while having wisdom teeth removed. The sedation produced by dexmedetomidine is unique in that it mimics natural sleep, a unique quality not shared by other drugs. Dexmedetomidine is often used in anesthesia in hospital operating rooms and has been approved by the US Food and Drug Administration for the use planned in this study.

Key facts

Study ID

NCT01017237

Run by

University of North Carolina, Chapel Hill

People needed

18

Starts

2009-07-01

Expected to finish

2011-12-01

Last updated by the study team

2013-06-17

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• American Society of Anesthesiology (ASA) physical status I and II
• Four asymptomatic third molars indicated for removal

You may not qualify if…

• Clinical history or ECG evidence of:
• cardiac dysrhythmia or heart block
• ischemic heart disease
• asthma
• sleep apnea
• impaired liver, renal, or mental function
• chronic sedative or analgesic use
• allergies to any of the study drugs
• history of pericoronal infection with third molars

Where it is running

• University of North Carolina School of Dentistry — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.